DLA Piper has appointed Abrar Hussain as a partner in its emerging growth and venture capital practice in Palo Alto. Hussain brings over 25 years of experience in the investment funds, biotech, and financial services sectors. His expertise encompasses fund formation, operations, fundraising, limited partnership negotiations, portfolio company support, complex mergers and acquisitions, initial public offerings, licensing, and cross-border transactions. Prior to joining DLA Piper, Hussain was affiliated with Samsara BioCapital. ([news.bloomberglaw.com](https://news.bloomberglaw.com/california-brief/dla-piper-adds-venture-capital-partner-hussain-in-palo-alto?utm_source=openai))
This appointment is part of DLA Piper’s ongoing efforts to strengthen its presence in Silicon Valley. In February 2026, the firm welcomed Josh Seidenfeld as chair of its Northern California corporate and securities practice in Palo Alto. Seidenfeld, formerly of Cooley LLP, has a background in guiding life sciences and technology companies through various stages of corporate development, including venture financings, mergers and acquisitions, and capital markets transactions. ([news.bloomberglaw.com](https://news.bloomberglaw.com/business-and-practice/dla-piper-recruits-cooley-palo-alto-health-tech-finance-partner-1?utm_source=openai))
Additionally, in August 2025, DLA Piper added Brady L. Berg as a partner in its Palo Alto office. Berg has approximately 30 years of experience representing emerging growth technology companies and venture capital investors. His background includes serving as General Counsel for an AI-based cybersecurity company that was sold for approximately $1.5 billion. ([dlapiper.com](https://www.dlapiper.com/en-gl/people/b/berg-brady?utm_source=openai))
These strategic hires reflect DLA Piper’s commitment to enhancing its capabilities in the technology and venture capital sectors, aligning with the dynamic business environment of Silicon Valley.